Global Smart Pills Market Size, Trends & Analysis - Forecasts to 2026 By Application (Product [Capsule Endoscopy and Drug Delivery], Tools, and Patient Monitoring Software), Competitive Landscape, Company Market Share Analysis, and Competitor Analysis
Smart pills have arisen as a game-changing technical advancement, bridging the global digital-healthcare system. The introduction of these healthcare-related technical devices has made it possible to meet the growing need for improved surveillance and diagnostics. Smart pills have now established themselves as a standard method for the non-invasive evaluation of motility disorders. Doctors prefer smart pills because they allow for real-time patient supervision through remote control alternatives.
Smart pills are ingestible prescription instruments that are the size of a capsule. Smart pills are employed for opioid distribution, prognosis, and recovery. The geriatric population and associated diseases like paralysis are driving the demand for on-site diagnosis. Increasing cases of chronic diseases such as diabetes, cancer, and others, as well as the prevalence of lifestyle disorders such as obesity, gastroesophageal reflux disease, and gastric ulcers, are also anticipated to fuel the market development.
Drug delivery systems with essential advantages like limited side/adverse effects, targeted drug delivery, optimum API usage, and decreased dose frequency have seen an increase in demand. As a result, new medicines, emerging technology, and medical applications have been integrated into drug delivery systems, resulting in the invention of smart pills which will witness substantial growth globally. Additionally, people with chronic conditions that must adhere to a strict prescription regimen are expected to be the target customer pool for smart pills.
Several smart pills are currently being studied for future medicinal and diagnostic applications in a variety of acute and chronic diseases. Furthermore, the increasing trend toward minimally invasive surgeries has culminated in new procedures like capsule endoscopy, which is supporting the overall growth prospects of smart pills. Along with hybrid imaging technology and new element developments, capsule endoscopy plays an important part in the early detection and appropriate care of these diseases. Patients who have a high need for home healthcare facilities face difficulties in obtaining and using smart pills. As a result, developers and manufacturers have increased the simplicity and reliability of these applications, making data interpretation easier for even the most inexperienced user. All these factors are eventually leading to exponential development in the smart pills market.
The majority of companies are now selling software solutions for gathering data over prolonged periods and disseminating useful knowledge about patient welfare as well as tips for increasing their standard of living. The ability to connect to smartphones through Bluetooth, as well as the availability of data in a user-friendly and numerical format, is expected to boost the smart pill market soon.
A smart drug delivery pill is regulated by electronics that has a lot of versatility & precision in terms of dosage, delivery venue and release time. At the same time, the pills can be used to track the local GI area, register readings in real-time, and be operated by an operator to execute an operation on request. Wireless connectivity allows for the exchange of real-time information, so smart pills minimize the need for invasive procedures. Long-term monitoring from inside the body is now largely adopted owing to advancements in battery processing (which has longer life) and onboard storage. Moreover, smart pills are expected to play an important role in remote patient care and telemedicine in the coming time. With traditional oral medication formulations, such multi-dimensional success is unlikely. Additionally, smart pills have revolutionized the management of gastrointestinal conditions, and they are likely to supplant traditional surgical methods such as endoscopy. For medical purposes, an endoscopy device is implanted into a patient's esophagus, followed by the upper and lower alimentary canal. These numerous trends will drive the market throughout the forecast period.
The elevated cost and severe health complications correlated with smart pill intake would stymie the development of the smart pill technology market over the forecast period. Smart pills have many benefits in diabetes diagnosis, medication control, and drug distribution, but they can have serious adverse effects on the patient's health. These health consequences of smart pill use can have a detrimental effect on the market. However, various research & development projects are being carried out by notable pharmaceutical companies to ensure that there are minimal side effects of consuming smart pills. Thus, it is foreseen that the global market for the smart pill will witness skyrocketing demand throughout the forecast period.
Depending on the application, the smart pills market is classified as product, tools, and patient monitoring software. The product segment is further classified as capsule endoscopy and drug delivery. The product segment, which contains the individual pill or capsule that patients consume, is likely to lead in this market. The product segment will maintain its supremacy throughout the forecast period due to factors like the disposable value of capsules, repeated use, and high cost.
The most prominent functional field for smart pills is capsule endoscopy. Capsule endoscopy is a significant application field since smart pills are employed to manage GI disorders such as Crohn's disease, obscure GI leakage, celiac disease, and small intestine tumors. Such pills are designed to target the small intestine, which is considered the gold standard when GI bleeding is expected. The traditional scopes employed for colonoscopy are painful for the patients. This has strengthened the market for smart pills and also this segment.
Since these pills have transformed the management of gastrointestinal diseases, they are likely to replace traditional endoscopy in some cases. As a result of the ongoing advances in the field of endoscopy, as well as the growing need for better diagnosis of gastrointestinal disorders, the market under consideration is projected to expand rapidly over the forecast period.
As per the geographical analysis, the market can be classified into North America (the US, Canada, and Mexico), Asia Pacific (India, China, Japan, Malaysia, Singapore, and Rest of Asia Pacific), Europe (Germany, United Kingdom, Italy, France, Spain, Netherlands, and Rest of Europe), Middle East & Africa and Central South America. North America will tend to be the most profitable market for smart pills, due to factors like rapid regulatory acceptance of new drugs, rising colorectal cancer reports, and technical advances in the healthcare field.
The Asia-Pacific market is foreseen to grow rapidly, following North America. Key factors impacting market growth in APAC include compulsory health insurance provisions and the rising prevalence of gastrointestinal diseases & stomach cancer. The rising incidence of target diseases, combined with increased government funding, is expected to fuel growth in the APAC smart pill market.
Olympus Corporation, Proteus Digital Health, Inc., CapsoVision, Inc., Medtronic, FUJIFILM Holdings Corporation, RF Co., Ltd., Check-Cap, BDD Limited, JINSHAN Science & Technology, Medisafe, PENTAX Medical, and IntroMedic Co. Ltd. are the top players in the smart pills market.
Please note: This is not an exhaustive list of companies profiled in the report.
Chapter 1 Methodology
1.1 Market Scope & Definitions
1.2 Estimates & Forecast Calculation
1.3 Historical Data Overview And Validation
1.4 Data Sources
Chapter 2 Report Outlook
2.1 Smart Pills Industry Overview, 2019-2026
2.1.1 Industry Overview
2.1.2 Application Overview
2.1.3 Regional Overview
Chapter 3 Smart Pills Market Trends
3.1 Market Segmentation
3.2 Industry Background, 2019-2026
3.3 Market Key Trends
3.3.1 Positive Trends
220.127.116.11 Technology Advancement in Healthcare Industry
18.104.22.168 Increasing R&D activities
3.3.2 Industry Challenges
22.214.171.124 The Increasing Government Restrictions
3.4 Prospective Growth Scenario
3.4.1 Application Growth Scenario
3.5 COVID-19 Influence over Industry Growth
3.6 Porter’s Analysis
3.7 PESTEL Analysis
3.8 Value Chain & Supply Chain Analysis
3.9 Regulatory Framework
3.9.1 North America
3.10 Technology Overview
3.11 Market Share Analysis, 2020
3.11.1 Company Positioning Overview, 2020
Chapter 4 Smart Pills Market, By Application
4.1 Application Outlook
4.2.1 Market Size, By Region, 2019-2026 (USD Million)
126.96.36.199 Capsule Endoscopy
188.8.131.52.1 Market Size, By Region, 2019-2026 (USD Million)
184.108.40.206 Drug Delivery
220.127.116.11.1 Market Size, By Region, 2019-2026 (USD Million)
4.3.1 Market Size, By Region, 2019-2026 (USD Million)
4.4 Patient Monitoring Software
4.4.1 Market Size, By Region, 2019-2026 (USD Million)
Chapter 5 Smart Pills Market, By Region
5.1 Regional outlook
5.2 North America
5.2.1 Market Size, By Country 2019-2026 (USD Million)
5.2.2 Market Size, By Application, 2019-2026 (USD Million)
18.104.22.168 Market Size, By Application, 2019-2026 (USD Million)
22.214.171.124 Market Size, By Application, 2019-2026 (USD Million)
5.3.1 Market Size, By Country 2019-2026 (USD Million)
5.3.2 Market Size, By Application, 2019-2026 (USD Million)
126.96.36.199 Market Size, By Application, 2019-2026 (USD Million)
188.8.131.52 Market Size, By Application, 2019-2026 (USD Million)
184.108.40.206 Market Size, By Application, 2019-2026 (USD Million)
220.127.116.11 Market Size, By Application, 2019-2026 (USD Million)
18.104.22.168 Market Size, By Application, 2019-2026 (USD Million)
22.214.171.124 Market Size, By Application, 2019-2026 (USD Million)
5.4 Asia Pacific
5.4.1 Market Size, By Country 2019-2026 (USD Million)
5.4.2 Market Size, By Application, 2019-2026 (USD Million)
126.96.36.199 Market Size, By Application, 2019-2026 (USD Million)
188.8.131.52 Market Size, By Application, 2019-2026 (USD Million)
184.108.40.206 Market Size, By Application, 2019-2026 (USD Million)
220.127.116.11 Market Size, By Application, 2019-2026 (USD Million)
5.4.7 South Korea
18.104.22.168 Market Size, By Application, 2019-2026 (USD Million)
5.5 Latin America
5.5.1 Market Size, By Country 2019-2026 (USD Million)
5.5.2 Market Size, By Application, 2019-2026 (USD Million)
22.214.171.124 Market Size, By Application, 2019-2026 (USD Million)
126.96.36.199 Market Size, By Application, 2019-2026 (USD Million)
188.8.131.52 Market Size, By Application, 2019-2026 (USD Million)
5.6.1 Market Size, By Country 2019-2026 (USD Million)
5.6.2 Market Size, By Application, 2019-2026 (USD Million)
5.6.3 Saudi Arabia
184.108.40.206 Market Size, By Application, 2019-2026 (USD Million)
220.127.116.11 Market Size, By Application, 2019-2026 (USD Million)
5.6.5 South Africa
18.104.22.168 Market Size, By Application, 2019-2026 (USD Million)
Chapter 6 Company Landscape
6.1 Competitive Analysis, 2020
6.2 Olympus Corporation
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Strategic Positioning
6.2.4 Info Graphic Analysis
6.3 Proteus Digital Health, Inc.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Strategic Positioning
6.3.4 Info Graphic Analysis
6.4 CapsoVision, Inc.
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Strategic Positioning
6.4.4 Info Graphic Analysis
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Strategic Positioning
6.5.4 Info Graphic Analysis
6.6 FUJIFILM Holdings Corporation
6.6.2 Financial Analysis
6.6.3 Strategic Positioning
6.6.4 Info Graphic Analysis
6.7 RF Co., Ltd.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Strategic Positioning
6.7.4 Info Graphic Analysis
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Strategic Positioning
6.8.4 Info Graphic Analysis
6.9 BDD Limited
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Strategic Positioning
6.9.4 Info Graphic Analysis
6.10 JINSHAN Science & Technology
6.10.2 Financial Analysis
6.10.3 Strategic Positioning
6.10.4 Info Graphic Analysis
6.11.1 Company Overview
6.11.2 Financial Analysis
6.11.3 Strategic Positioning
6.11.4 Info Graphic Analysis
6.12 PENTAX Medical
6.12.1 Company Overview
6.12.2 Financial Analysis
6.12.3 Strategic Positioning
6.12.4 Info Graphic Analysis
6.13 IntroMedic Co. Ltd.
6.13.1 Company Overview
6.13.2 Financial Analysis
6.13.3 Strategic Positioning
6.13.4 Info Graphic Analysis
6.14 Other Companies
6.14.1 Company Overview
6.14.2 Financial Analysis
6.14.3 Strategic Positioning
6.14.4 Info Graphic Analysis
The Global Smart Pills Market has been studied from the year 2019 till 2026. However, the CAGR provided in the report is from the year 2021 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Smart Pills Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?